Evidence map›Paper›PMID 35976476›Full record

SynthesisNeurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology2022

A systematic review on the risk of neurodegenerative diseases and neurocognitive disorders in professional and varsity athletes.

G Bellomo, P Piscopo, M Corbo, E Pupillo, G Stipa, E Beghi, N Vanacore, E Lacorte

Open access · hybridAbstract readSystematic Review
In one paragraph

Synthesis in Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 18 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
18citing papers in PubMed, 1 pooled it
3.7field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

18 citing papers in PubMed, 1 synthesis or guideline pooled it, 30 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Review
  4. Review
  5. Towards effective interventions: scoping review on prevention and modifiable risk factors of neurodegenerative diseases.Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology · 2025
    Article
  6. Review
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Review
  16. Article
  17. Article
  18. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 3 institutions in 2 countries.

G BellomoNational Center for Disease Prevention and Health Promotion, Italian National Institute of Health, Rome, Italy. guido.bellomo@iss.it.ORCID http://orcid.org/0000-0002-6549-3534
P PiscopoDepartment of Neurosciences, Italian National Institute of Health, Rome, Italy.ORCID http://orcid.org/0000-0002-0693-4969
M CorboDepartment of Neurorehabilitation Sciences, Casa Cura Policlinico, Milan, Italy.ORCID http://orcid.org/0000-0003-0793-9830
E PupilloIstituto Di Ricerche Farmacologiche Mario Negri IRCCS, Milan, Italy.ORCID http://orcid.org/0000-0003-4420-8076
G StipaClinical Neurophysiology Division, Neuroscience Department, S. Maria University Hospital, Terni, Italy.ORCID http://orcid.org/0000-0001-9474-9618
E BeghiIstituto Di Ricerche Farmacologiche Mario Negri IRCCS, Milan, Italy.ORCID http://orcid.org/0000-0003-2542-0469
N VanacoreNational Center for Disease Prevention and Health Promotion, Italian National Institute of Health, Rome, Italy.ORCID http://orcid.org/0000-0003-2817-3758
E LacorteNational Center for Disease Prevention and Health Promotion, Italian National Institute of Health, Rome, Italy.ORCID http://orcid.org/0000-0001-8530-9207
Istituto Superiore di Sanità · ITMario Negri Institute for Pharmacological Research · ITSanta Maria Nuova Hospital · IT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectiveThe aim of this systematic review (SR) was to gather all available epidemiological evidence on former participation in any type of sport, at a professional and varsity level, as a potential risk factor for neurodegenerative diseases (NDs) and neurocognitive disorders (NCDs).

designSystematic searches were performed on PubMed, the Cochrane databases, and the ISI Web of Knowledge databases. Included studies were assessed using the NOS checklist. ELIGIBILITY CRITERIA FOR SELECTING STUDIES: All epidemiological studies reporting data on the possible association between a clinical diagnosis of amyotrophic lateral sclerosis (ALS)/motor neuron disease (MND), dementia or mild cognitive impairment (MCI), Parkinson's disease (PD), chronic traumatic encephalopathy (CTE) at any stage and with any clinical pattern and the former participation in any types of sport at a varsity and professional level were included.

resultsData from the 17 included studies showed a higher frequency of NDs and NCDs in former soccer and American football players. Updating the previous SR confirmed a higher frequency of ALS/MND in former soccer players. Data reported a significantly higher risk of dementia/AD in former soccer players, and of MCI in former American football players. Results also showed a significantly higher risk of PD in former soccer and American football players, and a significantly higher risk of CTE in former boxers and American football players. This SR confirmed a higher risk of NDs and NCDs in former professional/varsity athletes. However, the pathological mechanisms underlying this association remain unclear, and further high-quality studies should be performed to clarify whether the association could be sport specific.

Indexed as

Amyotrophic Lateral SclerosisChronic Traumatic EncephalopathyCognitive DysfunctionDementiaFootballNeurodegenerative DiseasesParkinson DiseaseSoccerAthletesHumansAthletesClinical epidemiologyNeurodegenerative diseasesRisk factorsSystematic review

Identifiers

PMID35976476
PMCPMC9663371
OpenAlexW4292162818

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.